Melanoma News

 
 
  • AAD Aggressive Skin Cancer Rates Skyrocketing The incidence of Merkel cell carcinoma is increasing exponentially as the US population ages, a new national study shows.
  • AAD Acne Can Be More Harmful Than Melanoma Inflammatory skin diseases cause more harm than skin cancers when years of disability and mortality are added together, according to the latest report from the Global Burden of Disease Study.
  • GUCS 'Really Durable Benefit' Emerging With Bladder Cancer ImmunoTx Overall survival curves in cancer treatment trials typically go down with time. It's a big deal when survival stabilizes and a flat 'tail' emerges as patients remain alive much longer.
  • Intriguing: Better Survival in Melanoma in Obese Men Observations across cohorts of patients treated for metastatic melanoma have led to an intriguing conclusion: survival is better in obese patients, but only for men.
  • New Guidelines for Treating Checkpoint Inhibitor Toxicities ASCO and the NCCN have issued joint guidelines for treating toxicities associated with checkpoint inhibitor treatment.
  • CSS No Follow-up in More Than a Third of AYA Cancer Survivors A large proportion of adolescent and young adult (AYA) cancer survivors are not receiving follow-up care after the end of their active treatment.
  • Young People Often Face Delays in Cancer Diagnosis Adolescents and young adults may have long delays between the onset of cancer symptoms and being diagnosed, according to data from the UK.
  • AAD Immune Modulation in the Spotlight at AAD 2018 Immunomodulators for inflammatory diseases and cancer will be among the hot topics at the upcoming American Academy of Dermatology meeting.
  • Good News, Bad News About Melanoma for US Whites In the latest melanoma incidence data, younger adults had decreased rates but older adults had a steady increase. 'Older' begins at age 54 for men and age 44 for women.
  • Clinical Cancer Advance of the Year Is CAR T Cells In its annual review of clinical cancer advances, the American Society of Clinical Oncology highlights CAR T cells as having 'historical significance.'
  • Experts Welcome Adjuvant Nivolumab for Melanoma The PD-1 inhibitor nivolumab was recently approved by the FDA for adjuvant use in completely resected stage III or IV melanoma, a move welcomed by experts in the field.
  • Beta-Blockers May Enhance Immunotherapy for Melanoma A chart review study suggests that pan-beta-blockers, such as propranolol, may improve outcomes in metastatic melanoma.
  • Cancer Death Rates Continue to Fall in US -- Why? Cancer-related mortality rates continue to decline across the United States, with some of the largest decreases seen in lung cancer among men between 1990 and 2015.
  • For Five Cancers, Screening Skews Risk Factors Cancer risk factors are typically based on characteristics at the time of diagnosis. In a new essay, a pair of major figures on the US cancer scene explain why that is a problem when cancers are detected by testing.
  • SRS for Brain Mets: Use Is Up, but Restricted Use of stereotactic radiosurgery (SRS) to treat brain metastases has increased significantly in recent years. But some patients are more likely to receive it than others.
  • Age No Bar to Immunotherapy for Metastatic Melanoma After immunotherapy for metastatic melanoma, patients over age 65 appear to show equivalent, and perhaps better, clinical outcome than their younger counterparts, according to a small retrospective study from France.
  • Hairdressers Doing Scalp Exams Could Save Lives On self-examination, 50% of melanomas go undetected. They frequently show up on the head and neck. Could hairdressers be trained to conduct frontline population-based screening?
  • In US, 4 out of 10 Cancers Could Be Prevented Potentially modifiable risk factors account for a large proportion of all cancer cases and cancer-related deaths in men and women living in the US.
  • Good Gut Microbes May Help Immunotherapy Drugs Shrink Tumors Cancer patients with high levels of good gut bacteria appear more likely to respond to immunotherapy, potentially opening up a new way to optimize the use of modern medicines that are highly effective but only work in some people.
  • Tanning Salons Often Ignore Laws Restricting Use by Minors More than one-third of indoor tanning salons don’t follow state laws limiting use by children and teens, a U.S. study suggests.